about
Regulating off-label drug use in India: The arena for concernDrug-induced renal damage in preterm neonates: state of the art and methods for early detectionChildren with multiple sclerosis should not become therapeutic hostagesPerispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceRegulatory science needs for neonates: a call for neonatal community collaboration and innovationObjective consensus from decision treesPlacebo-controlled trials in pediatrics and the child's best interest.Successful nilotinib treatment in a child with chronic myeloid leukemiaChanging patterns of alpha agonist medication use in children and adolescents 2009-2011Acetylcysteine and Acetaminophen Overdose: The Many Shades of GrayMedication Repurposing in Pediatric Patients: Teaching Old Drugs New TricksOptimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.Off-label use of orphan medicinal products: a Belgian qualitative study.Ethics of pharmacological research involving adolescents.An ethical framework for responding to drug shortages in pediatric oncology.Use of pharmacogenomics in pediatric renal transplant recipients.Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists.Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.Clinical Trial Design in Juvenile Idiopathic Arthritis.Administration of Inhaled Pulmonary Vasodilators to the Mechanically Ventilated Neonatal Patient.Current needs in pediatric pharmacoepidemiology.How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians.Scalpels not hammers: The way forward for precision drug prescription.Immediate neurological recovery following perispinal etanercept years after brain injury.Trends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013.Prescribing errors in a Brazilian neonatal intensive care unit.Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.Prescribing practice and off-label use of psychotropic medications in post-acute brain injury rehabilitation centres: a cross-sectional survey.An Algorithm to Identify Compounded Non-Sterile Products that Can Be Formulated on a Commercial Scale or Imported to Promote Safer Medication Use in ChildrenCreating a Distinct Medication-Use System for Children at the Point of Care: The Time is Now.Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.Enhancing clinical trial development for pediatric kidney diseases.Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development.Therobotat the sideof the nurse: present situation and prospects.Off-label Prescribing Trends for ADHD Medications in Very Young Children.HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?The 2015 French guidelines on alcohol misuse, issued in partnership with the European Federation of Addiction Societies: a focus on children and adolescents.Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.
P2860
Q26801036-72DAD783-43C6-4211-83ED-7DCE1D39F380Q26849339-06E32B2E-8EA8-4FEA-A1C1-C0D98E7F89D3Q28077271-010B6B1F-14FD-4F50-8F00-971F95CB5638Q33947639-64A8FFA3-817B-481E-9BCF-144E1708BFC5Q34593375-AA05DC0C-82EC-4C70-81F5-CD966CAEB9DFQ34727909-EBEC1E24-C300-43BA-8B5B-48F8A64DBE1CQ35136434-D03DAB22-56F0-4DD3-8497-FA6F63DCC2AFQ35225342-C38640E7-600E-4371-BDD3-FE946071CE59Q35641630-7A244519-E17D-44E7-8431-2E2D5FC62832Q35754032-D886BFF2-3C9A-414C-92BD-054CF45FCBAAQ36652800-57EE2508-C6CC-4B2B-89DB-3B7146247104Q37203671-1C6B7CDE-CB5A-4332-B3EC-237EC02F2EE7Q37377924-E006D42B-835F-4D98-B9B2-83492E233793Q38293664-E8CD499E-7FFD-4E39-AA9B-1FC48871BCBBQ38366900-B12B4115-E0CD-421D-88E4-F14900429652Q38367819-0E9915DF-7F56-462E-B100-87543F478E1DQ38604722-B4BDDBEF-BC71-4840-813C-E3EC674D55CDQ38614896-E3C31A8C-3101-47DC-9861-234C90A2AB29Q38645148-B9FFEDE1-D3F2-4B25-A19B-41074A9577BCQ38671265-24591AF4-740F-47BA-8CDC-D3E93BB32D2CQ38857128-02FC5ACE-6157-451C-993A-1B88443EB258Q38903940-240CA9C6-E3B0-422A-9F4E-7CC28F857554Q38965300-D8A83F23-97EA-41C7-8B01-F175E443DBBDQ39041485-766EC643-F28F-4D31-A06A-09E600E8F547Q39209875-3B484B65-F900-4591-84D0-1801BD654E3EQ39853460-FE15B9DA-13D5-4019-9C23-57B875FEA6EDQ40001174-B5C277CD-CBC5-403A-BB4E-8EE1D0F7FAA8Q40405030-427D1D95-CEA9-4CED-A893-DF06257BE350Q41639338-BCBA2BF4-502C-4C75-B20B-2DEEF3458825Q42019687-D1F3E01D-E0B7-4935-8D60-290C0BEF9E5EQ42024295-7FD5BEC5-1767-4BCA-BBAA-484C64790AE2Q42840586-5FD80631-906D-4171-9BA5-C6E595F4324EQ46096552-ED80ADE1-5114-4129-A61D-0D35BADFC114Q46330140-6A2AD0D3-8C44-46FE-BA17-E8C6C72FB26DQ46788549-DE96BABF-45A4-446D-B7B0-78F06ED1C6D9Q47164989-50CAC1D9-559A-4B7D-B9B4-DAB557C44EEAQ47303141-1E4F3A44-725A-4BDB-BC1B-79D07D99C74EQ48007338-09B92230-AA32-416D-A7C9-E0B72B06EEE3Q48013513-92DC567E-B7CA-483A-8249-0F73FD5C8BA6Q50027860-0DE66806-D922-406F-88BC-BA0AB78F6891
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Off-label use of drugs in children.
@ast
Off-label use of drugs in children.
@en
Off-label use of drugs in children.
@nl
type
label
Off-label use of drugs in children.
@ast
Off-label use of drugs in children.
@en
Off-label use of drugs in children.
@nl
prefLabel
Off-label use of drugs in children.
@ast
Off-label use of drugs in children.
@en
Off-label use of drugs in children.
@nl
P2093
P356
P1433
P1476
Off-label use of drugs in children.
@en
P2093
American Academy of Pediatrics Committee on Drugs
Daniel A Frattarelli
Jeffrey L Galinkin
John N Van Den Anker
Kathleen A Neville
Thomas P Green
Timothy D Johnson
P304
P356
10.1542/PEDS.2013-4060
P407
P50
P577
2014-02-24T00:00:00Z